Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
20
ATRA Quote, Financials, Valuation and Earnings
Last price:
$6.91
Seasonality move
:
-15.4%
Day range:
$7.17 - $7.60
52-week range:
$5.40 - $20.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.42x
P/B ratio:
--
Volume:
49.9K
Avg. volume:
87.8K
1-year change:
-53.8%
Market cap:
$42M
Revenue:
$128.9M
EPS (TTM):
-$12.97
Earnings Data
Next earnings date for ATRA
May 09
2025
Most recent earnings per share
-$1.19
Beat by $2.30
(Mar 7/2025)
Consensus Estimate
-$3.49
(Mar 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ATRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/09/2025 | Q1 | $3.4M | -- | -- | -$2.19 | -- |
| 03/07/2025 | Q4 | $16.6M | $32.8M | -$1.19 | -$3.49 | $2.30 |
| 11/12/2024 | Q3 | $35.2M | $40.2M | -$2.93 | -$3.50 | $0.57 |
| 08/12/2024 | Q2 | $37.1M | $28.6M | -$3.10 | -$2.24 | -$0.86 |
| 05/09/2024 | Q1 | $24.7M | $27.4M | -$5.75 | -$6.42 | $0.67 |
| 03/28/2024 | Q4 | $14.3M | $4.3M | -$13.98 | -$12.05 | -$1.93 |
| 11/01/2023 | Q3 | $1.3M | $2.1M | -$16.40 | -$16.40 | -- |
| 08/08/2023 | Q2 | $3.8M | $957K | -$16.91 | -$16.51 | -$0.40 |
| 05/08/2023 | Q1 | $30.7M | $1.2M | -$18.00 | -$9.51 | -$8.49 |
| 02/08/2023 | Q4 | $39.7M | $221K | -$18.00 | -$9.70 | -$8.30 |
| 11/08/2022 | Q3 | $3.7M | $4.5M | -$20.50 | -$19.34 | -$1.16 |
| 08/08/2022 | Q2 | -- | $51.6M | $4.50 | -- | -- |
| 05/05/2022 | Q1 | -- | $7.3M | -$21.75 | -- | -- |
| 02/28/2022 | Q4 | -- | $7.5M | -$24.00 | -- | -- |
| 11/04/2021 | Q3 | -- | $5.4M | -$22.50 | -- | -- |
| 08/09/2021 | Q2 | -- | $3.9M | -$22.75 | -- | -- |
| 05/04/2021 | Q1 | -- | $3.6M | -$21.50 | -- | -- |
| 03/01/2021 | Q4 | -- | -- | -$23.75 | -- | -- |
| 11/09/2020 | Q3 | -- | -- | -$23.00 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | -$28.50 | -- | -- |
| 05/06/2020 | Q1 | -- | -- | -$30.00 | -- | -- |
| 02/27/2020 | Q4 | -- | -- | -$34.00 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | -$32.75 | -- | -- |
| 08/08/2019 | Q2 | -- | -- | -$40.00 | -- | -- |
| 05/09/2019 | Q1 | -- | -- | -$36.00 | -- | -- |
| 02/26/2019 | Q4 | -- | -- | -$43.75 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | -$32.25 | -- | -- |
| 08/01/2018 | Q2 | -- | -- | -$28.75 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$26.25 | -- | -- |
| 02/27/2018 | Q4 | -- | -- | -$28.75 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -$25.50 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | -$23.50 | -- | -- |
| 05/04/2017 | Q1 | -- | -- | -$22.00 | -- | -- |
| 03/09/2017 | Q4 | -- | -- | -$15.75 | -- | -- |
| 11/04/2016 | Q3 | -- | -- | -$22.00 | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -$16.50 | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -$14.50 | -- | -- |
| 03/03/2016 | Q4 | -- | -- | -$18.75 | -- | -- |
| 11/11/2015 | Q3 | -- | -- | -$10.75 | -- | -- |
| 08/06/2015 | Q2 | -- | -- | -$15.50 | -- | -- |
| 05/28/2015 | Q1 | -- | -- | -$10.50 | -- | -- |
Atara Biotherapeutics Earnings Questions
-
How Much did Atara Biotherapeutics Generate in Revenue Last Quarter?
Atara Biotherapeutics reported $32.8M worth of top line sales in its most recent quarter.
-
Did Atara Biotherapeutics Beat Earnings Last Quarter?
Atara Biotherapeutics announced earnings per share of -$1.19 which represents a beat of analyst forecast a -$3.49 per share.
-
Is Atara Biotherapeutics Profitable?
Atara Biotherapeutics reported $26M that represents $2.42 per share over the last quarter.
-
What is the Analyst Consensus for Atara Biotherapeutics EPS Next Year?
Atara Biotherapeutics's earnings are forecast to decrease from -$11.41 per share to -$4.24 per share next year representing a decrease of -48.79%.
-
When is Atara Biotherapeutics's Earnings Date?
Atara Biotherapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
